Researchers have uncovered a previously unrecognized role for immune cell surface sugars in driving inflammation in psoriasis. Scientists have refined how they understand the role of sugars called ...
TipRanks on MSN
Sino Biopharm’s oral psoriasis drug TQH3906 delivers biologic-like efficacy in phase II trial
Sino Biopharmaceutical ( ($HK:1177) ) has provided an update. Sino Biopharmaceutical has reported positive Phase II clinical trial results for ...
A new study published in the Journal of American Medical Association showed that psoriasis patients who used antibiotics had ...
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small ...
Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...
In the second half of his Maui Derm recap, George Martin, MD, founder and program director of the meeting, highlights new ...
Zacks Investment Research on MSN
JNJ's Tremfya gets EU approval for pediatric plaque psoriasis
Johnson & Johnson JNJ announced that the European Commission (EC) has approved an expanded use of its blockbuster psoriasis ...
Samsung Bioepis Co. Ltd. has announced the marketing approval of Ustekinumab BS Subcutaneous Injection 45mg Syringes 'NIPRO', ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback